ID   SRSF2_RAT               Reviewed;         221 AA.
AC   Q6PDU1;
DT   27-SEP-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   24-JUL-2024, entry version 133.
DE   RecName: Full=Serine/arginine-rich splicing factor 2;
DE   AltName: Full=Splicing component, 35 kDa;
DE   AltName: Full=Splicing factor SC35;
DE            Short=SC-35;
DE   AltName: Full=Splicing factor, arginine/serine-rich 2;
GN   Name=Srsf2; Synonyms=Sfrs2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pituitary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   INTERACTION WITH CCNL1.
RX   PubMed=11683997; DOI=10.1016/s0896-6273(01)00465-2;
RA   Berke J.D., Sgambato V., Zhu P.-P., Lavoie B., Vincent M., Krause M.,
RA   Hyman S.E.;
RT   "Dopamine and glutamate induce distinct striatal splice forms of Ania-6, an
RT   RNA polymerase II-associated cyclin.";
RL   Neuron 32:277-287(2001).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-26; SER-189; SER-191;
RP   SER-206; SER-208 AND SER-212, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Necessary for the splicing of pre-mRNA. It is required for
CC       formation of the earliest ATP-dependent splicing complex and interacts
CC       with spliceosomal components bound to both the 5'- and 3'-splice sites
CC       during spliceosome assembly. It also is required for ATP-dependent
CC       interactions of both U1 and U2 snRNPs with pre-mRNA. The phosphorylated
CC       form (by SRPK2) is required for cellular apoptosis in response to
CC       cisplatin treatment (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: In vitro, self-associates and binds SRSF1/SFRS1 (ASF/SF2),
CC       SNRNP70 and U2AF1 but not U2AF2. Binds SREK1/SFRS12. Interacts with
CC       CCNL2. Interacts with SCAF11. Interacts with ZRSR2/U2AF1-RS2. Interacts
CC       with CCDC55 (via C-terminus). Interacts with BRDT (By similarity).
CC       Interacts with CCNL1. {ECO:0000250, ECO:0000269|PubMed:11683997}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.
CC   -!- PTM: Extensively phosphorylated on serine residues in the RS domain.
CC       Phosphorylated by SRPK2 and this controls cell fate decision in
CC       response to cisplatin treatment. SRSF2 and SRPK2 cooperate to induce
CC       apoptosis through regulation of the splicing switch of caspase-8 pre-
CC       mRNA and in the absence of SRPK2, cisplatin-treated cells accumulate in
CC       G2/M phase. KAT5/TIP60 inhibits its phosphorylation by preventing SRPK2
CC       nuclear translocation (By similarity). {ECO:0000250}.
CC   -!- PTM: Acetylation on Lys-52 by KAT5/TIP60 promotes its proteasomal
CC       degradation. This effect is counterbalanced by HDAC6, which positively
CC       controls SRSF2 protein level by deacetylating it and preventing its
CC       proteasomal degradation (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the splicing factor SR family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC058508; AAH58508.1; -; mRNA.
DR   RefSeq; NP_001009720.1; NM_001009720.2.
DR   RefSeq; XP_006247875.1; XM_006247813.3.
DR   RefSeq; XP_008766604.1; XM_008768382.1.
DR   AlphaFoldDB; Q6PDU1; -.
DR   SMR; Q6PDU1; -.
DR   BioGRID; 268944; 2.
DR   IntAct; Q6PDU1; 4.
DR   MINT; Q6PDU1; -.
DR   STRING; 10116.ENSRNOP00000059012; -.
DR   iPTMnet; Q6PDU1; -.
DR   PhosphoSitePlus; Q6PDU1; -.
DR   jPOST; Q6PDU1; -.
DR   PaxDb; 10116-ENSRNOP00000059012; -.
DR   Ensembl; ENSRNOT00000067739.3; ENSRNOP00000059012.1; ENSRNOG00000000248.7.
DR   Ensembl; ENSRNOT00055054720; ENSRNOP00055045227; ENSRNOG00055031602.
DR   Ensembl; ENSRNOT00060040678; ENSRNOP00060033621; ENSRNOG00060023483.
DR   Ensembl; ENSRNOT00065007152; ENSRNOP00065004962; ENSRNOG00065004914.
DR   GeneID; 494445; -.
DR   KEGG; rno:494445; -.
DR   AGR; RGD:1359422; -.
DR   CTD; 6427; -.
DR   RGD; 1359422; Srsf2.
DR   eggNOG; KOG4207; Eukaryota.
DR   GeneTree; ENSGT00940000154883; -.
DR   HOGENOM; CLU_012062_10_3_1; -.
DR   InParanoid; Q6PDU1; -.
DR   OMA; PLIRCDV; -.
DR   OrthoDB; 3221998at2759; -.
DR   Reactome; R-RNO-159236; Transport of Mature mRNA derived from an Intron-Containing Transcript.
DR   Reactome; R-RNO-72163; mRNA Splicing - Major Pathway.
DR   Reactome; R-RNO-72165; mRNA Splicing - Minor Pathway.
DR   Reactome; R-RNO-72187; mRNA 3'-end processing.
DR   Reactome; R-RNO-72203; Processing of Capped Intron-Containing Pre-mRNA.
DR   Reactome; R-RNO-73856; RNA Polymerase II Transcription Termination.
DR   PRO; PR:Q6PDU1; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000000248; Expressed in thymus and 20 other cell types or tissues.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0035061; C:interchromatin granule; IDA:RGD.
DR   GO; GO:0016607; C:nuclear speck; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0005726; C:perichromatin fibrils; IDA:RGD.
DR   GO; GO:0005681; C:spliceosomal complex; ISO:RGD.
DR   GO; GO:0036002; F:pre-mRNA binding; ISO:RGD.
DR   GO; GO:0005080; F:protein kinase C binding; IPI:RGD.
DR   GO; GO:0003723; F:RNA binding; IBA:GO_Central.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; IBA:GO_Central.
DR   GO; GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; ISO:RGD.
DR   GO; GO:0033197; P:response to vitamin E; IEP:RGD.
DR   CDD; cd12311; RRM_SRSF2_SRSF8; 1.
DR   Gene3D; 3.30.70.330; -; 1.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR051106; RNA-bind/splicing_reg.
DR   InterPro; IPR000504; RRM_dom.
DR   InterPro; IPR003954; RRM_dom_euk.
DR   PANTHER; PTHR48028; GLYCINE-RICH RNA-BINDING PROTEIN RZ1A; 1.
DR   PANTHER; PTHR48028:SF4; SC35-LIKE SPLICING FACTOR; 1.
DR   Pfam; PF00076; RRM_1; 1.
DR   SMART; SM00360; RRM; 1.
DR   SMART; SM00361; RRM_1; 1.
DR   SUPFAM; SSF54928; RNA-binding domain, RBD; 1.
DR   PROSITE; PS50102; RRM; 1.
PE   1: Evidence at protein level;
KW   Acetylation; mRNA processing; mRNA splicing; Nucleus; Phosphoprotein;
KW   Reference proteome; RNA-binding.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q01130"
FT   CHAIN           2..221
FT                   /note="Serine/arginine-rich splicing factor 2"
FT                   /id="PRO_0000081921"
FT   DOMAIN          14..92
FT                   /note="RRM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   REGION          92..221
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        118..187
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        192..212
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01130"
FT   MOD_RES         2
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         22
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01130"
FT   MOD_RES         25
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01130"
FT   MOD_RES         26
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         52
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01130"
FT   MOD_RES         189
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         191
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         204
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01130"
FT   MOD_RES         206
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         208
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         212
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         220
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01130"
SQ   SEQUENCE   221 AA;  25476 MW;  68121AC4D35714FA CRC64;
     MSYGRPPPDV EGMTSLKVDN LTYRTSPDTL RRVFEKYGRV GDVYIPRDRY TKESRGFAFV
     RFHDKRDAED AMDAMDGAVL DGRELRVQMA RYGRPPDSHH SRRGPPPRRY GGGGYGRRSR
     SPRRRRRSRS RSRSRSRSRS RSRYSRSKSR SRTRSRSRST SKSRSARRSK SKSSSVSRSR
     SRSRSRSRSR SPPPVSKRES KSRSRSKSPP KSPEEEGAVS S
//
